-
Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page
Genoa Reporting Email
- Thread starter anonymous
- Start date
-
- Tags
- None
A bunch of my people fill all their patient scripts through Genoa. If they don’t report, how can we get credit?
so how are they going to figure out our goal attainment and payouts without this data
Short answer is they can’t. This will impact some territories a lot and some not at all. Now they have to figure out how to “play it” to avoid calling the third and fourth quarter reporting into question.
They are talking about this and our company on the Teva neuroscience website. Said they knew about it in July. At least we aren’t alone.
From the Teva NS thread:
"All this stems from the real problem that dates back to July. Genoa issues with reporting data and not knowing exactly how territories are performing. I have a buddy at Intra-Cellular and they are going through the same. A lot of venting on CafePharma about this situation with many companies since it is affecting all specialty pharma that sends scripts to SPs like Genoa. This compounded with all the changes at our Sr. leadership level was just a disaster waiting to happen, but yes, where is the communication to the field!"
This shouldn't be new news to anyone. Any IQVIA data reported that was supplied by their vendor reporting specialty pharmacy distribution, has been short to non-existent since late summer. There are several major pharma companies being affected by this including us. It's not unrealistic that we will be paid on projected data moving forward until this vendor fixes the issue or gets their act together.
It doesn’t impact everyone the same way. Some territories have little impact and they should be fine. But some of us are seeing top writers drop big time. The projected data isn’t working. Tough to trust this system.
Another pharma company rep here--we had a dramatic drop off beginning in July of this year. Entire teams under water and some not affected at all.
This sounds like a class action suit. We don't make goal, we don't make rankings, then we don't make a merit increase. Company still made money on the scripts sent thru Genoa.
This sounds like a class action suit. We don't make goal, we don't make rankings, then we don't make a merit increase. Company still made money on the scripts sent thru Genoa.
Psych rep here from another company. We didn’t make goal Q3 and didn’t understand. Like huge drop in attainment despite people saying they’re writing and writing. We knew of one or two Genoas not reporting but I guess it’s more than we thought. Sucks especially since they put these pharmacies in BH facilities.
Seen this play out before. The company makes their number and Wall Street expectations because the wholesale sales go to the bottom line once product ships. All the big shots, who don't actually have to meet a sales goal, get their high raises, promotions and stock. The field eats it and suffers with lower bonus, merit and stock. Not to mention threats and abuse every week from our managers. Some people will end up on PIPs because they won't get credit for HCPs who are writing prescriptions. This is a mess and they won't admit it or make it right. Bet on it.
Hit it
Nah, na-na-na-nah
Na-na-na-na, na-na-na, na-na-na
Na-na-na-nah
Nah, na-na-na-nah
Na-na-na-na, na-na-na, na-na-na
Na-na-na-nah
Here comes the hotstepper (murderer)
I'm the lyrical gangster (murderer)
Pick up the crew in-a de area (murderer)
Still love you like that (murderer)
No no we don't die, yes we multiply
Anyone press will hear the fat lady sing
Act like you know, Rico
I know what Bo don't know
Touch them up and go, uh-oh
Ch-ch-chang chang
Well the bonus is delayed again with no concrete payout date. Must be something to the reporting issues and rumors.